Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
M.D. Anderson Cancer Center · NCT04984551
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 312
- US sites recruiting
- 1
- Study start
- August 24, 2020
- Record last updated
- September 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.
Being studied: Extension of Community Health (ECHO) Telementoring Clinic; In-Country Workshops; Professional Oncology Educations Programs; Medical Chart Review; Questionnaire Administration
Conditions: Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
- PATIENT: 18 years or older
- PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
- PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
- PATIENT: Able to read and understand English as assessed by the treating physician
- CAREGIVER: Identified or self-identified as primary caregiver of the patient
- CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
- CAREGIVER: 18 years or older
- CAREGIVER: Able to read and understand English as assessed by the treating physician
- ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
- ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)
Exclusion Criteria
- Unable to understand and sign consent
Recruiting US locations
M D Anderson Cancer Center
Houston, TX 77030
Site contact: Sriram Yennu · 713-792-6085
Study contacts (from the official record)
- Sriram Yennu · 713-792-6085 · syennu@mdanderson.org
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75